Invesco Ltd. Has $12.51 Million Stock Position in Pediatrix Medical Group, Inc. $MD

Key Points

• Invesco Ltd. has increased its holdings in Pediatrix Medical Group, Inc. by 9.3%, acquiring 73,157 shares during the 1st quarter, bringing its total ownership to approximately 1.00% of the company, valued at around $12.5 million.
• Other institutional investors have also significantly increased their positions in Pediatrix, with investments from firms like GAMMA Investing LLC increasing their stake by 219.5% during the same period.
• Pediatrix Medical Group recently reported $0.53 EPS for the quarter, surpassing analysts' expectations, although the company's revenue declined 7.1% year-over-year.

Invesco Ltd. grew its holdings in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 9.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 863,269 shares of the company's stock after purchasing an additional 73,157 shares during the period. Invesco Ltd. owned about 1.00% of Pediatrix Medical Group worth $12,509,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in MD. GAMMA Investing LLC increased its holdings in shares of Pediatrix Medical Group by 219.5% in the 1st quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock valued at $37,000 after purchasing an additional 1,765 shares during the period. Tower Research Capital LLC TRC boosted its stake in shares of Pediatrix Medical Group by 218.0% during the 4th quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock valued at $98,000 after buying an additional 5,104 shares during the period. Squarepoint Ops LLC acquired a new stake in shares of Pediatrix Medical Group during the 4th quarter valued at $132,000. Sherbrooke Park Advisers LLC acquired a new stake in shares of Pediatrix Medical Group during the 4th quarter valued at $136,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management acquired a new stake in shares of Pediatrix Medical Group during the 1st quarter valued at $159,000. Institutional investors and hedge funds own 97.71% of the company's stock.

Pediatrix Medical Group Stock Up 0.5%

Shares of MD traded up $0.08 during mid-day trading on Friday, hitting $17.18. 710,110 shares of the company's stock were exchanged, compared to its average volume of 949,238. The firm has a fifty day moving average of $14.13 and a two-hundred day moving average of $14.04. The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.70. Pediatrix Medical Group, Inc. has a twelve month low of $10.06 and a twelve month high of $17.67. The stock has a market cap of $1.50 billion, a price-to-earnings ratio of 13.32 and a beta of 1.21.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 earnings per share for the quarter, topping analysts' consensus estimates of $0.42 by $0.11. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The business had revenue of $468.84 million during the quarter, compared to analysts' expectations of $464.37 million. During the same period in the previous year, the company earned $0.34 earnings per share. Pediatrix Medical Group's revenue for the quarter was down 7.1% on a year-over-year basis. On average, sell-side analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on MD shares. Zacks Research raised shares of Pediatrix Medical Group to a "strong-buy" rating in a research note on Monday, August 11th. Macquarie lifted their target price on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research note on Thursday, May 8th. Finally, UBS Group lifted their target price on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the company a "neutral" rating in a research note on Thursday, August 14th. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and four have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $16.75.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.